Upon examining previously published articles, we found that in different rat or mouse models of dementia, the length of BAI treatment used to determine its effects in improving learning and memory deficits generally ranged from 14 to 21 days.15, 31, 34, 35 Additionally, in our previous studies, the length of memantine and (‐)‐epigallocatechin‐3‐gallate treatment used to determine their effects on AD‐like behavior changes in APP/PS1 mice was customarily 4 weeks.20, 33 Therefore, the 33‐day treatment length used in this study should be long enough to reveal any anti‐AD properties of BAI. Here, APP is linked to Alzheimer disease.